Baltimore and Philadelphia consolidated their class-action lawsuits alleging that eight of the nation’s biggest banks, including Bank of America, JPMorgan Chase, and Citigroup, conspired to fix the prices on floating-rate bonds sold to finance public works, reported Bloomberg Law.
The consolidated complaint, filed May 31 in the Southern District of New York, also claims the banks violated their fiduciary duties to the cities by advising them to sell the variable-rate securities as the yields were being kept artificially high.
In February, Philadelphia accused Bank of America, Barclays, Citigroup, Goldman Sachs Group, JPMorgan Chase, Royal Bank of Canada, and Wells Fargo of secretly manipulating rates for tax-exempt bonds known as VRDOs, or variable-rate demand obligations.
Philadelphia, which stated it issued more than US$1.6 billion of the bonds, claimed the banks colluded to collect hundreds of millions of dollars in fees they did not earn, reducing critical funding for public services such as hospitals, power and water supplies, schools, and transportation.
“The alleged misconduct of the defendants potentially resulted in Philadelphia – and entities across this country -paying above-market interest rates for years,” City Solicitor Marcel Pratt said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas